论文部分内容阅读
作者应用微密度测定法(MD 法)对慢性肝病患者合并的骨病变进行了研究,并对一部分患者给予了活化型维生素 D_(?)(1α-OH-D_3)。对象是53例慢性肝病患者,其中慢性肝炎8例,肝硬变33侧(代偿性20例,非代偿性13例),肝细胞癌7例,原发性胆汁性肝硬变4例,自身免疫性肝炎1例。骨病变用第二中指骨 X 线片为标准。作者对其骨皮质幅指数(MCI)、骨髓质幅(d)、相当于骨皮质部加上骨髓质部的骨盐量指标(GSmin)、仅相当于骨皮质部的骨盐量指标(GSmax)、表明每个单位的平均骨盐量指标(∑GS/D)等项进行了测定,并统计各项
The authors studied the bone lesions in patients with chronic liver disease by micro-densitometry (MD method), and activated vitamin D_ (?) (1α-OH-D_3) in some patients. Subjects were 53 patients with chronic liver disease, including 8 cases of chronic hepatitis, cirrhosis 33 (compensatory 20 cases, 13 cases of uncompensated), hepatocellular carcinoma in 7 cases, 4 cases of primary biliary cirrhosis One case of autoimmune hepatitis. Bone lesions with the second phalanx X-ray as the standard. Cortical bone index (MCI), medullary mass (d), bone mineral content equivalent to cortical bone marrow mass index (GSmin), the equivalent of the cortical bone mineral volume index (GSmax ), Indicating that the average bone mineral content per unit index (ΣGS / D) and other items were measured, and statistics of